Page last updated: 2024-09-05

7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid and Psoriasis

7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid has been researched along with Psoriasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, DA; Fretland, DJ; Gokhale, R; Mathur, L; Paulson, SK; Stolzenbach, J1

Other Studies

1 other study(ies) available for 7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid and Psoriasis

ArticleYear
Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228.
    Inflammation, 1995, Volume: 19, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Benzopyrans; Disease Models, Animal; Drug Eruptions; Drug Evaluation, Preclinical; Ear, External; Edema; Female; Gels; Guinea Pigs; Humans; Male; Mice; Peroxidase; Psoriasis; Receptors, Leukotriene B4; Tetradecanoylphorbol Acetate

1995